Biohit Oyj
Biohit Oyj: Kari Syrjänen resigns as Chair of the Board of Directors
Biohit Oyj Stock Exchange Release 2.9.2026 at 5:00 p.m. (EEST)
The Chair of the Board of Directors of Biohit Oyj, Kari Syrjänen, has announced his resignation from the Board of Directors with effect from 2 September 2026.
The resignation is due to personal reasons.
The Board of Directors has elected current Board member Kalle Härkönen as its new Chair.
Additional information:
Jussi Hahtela, CEO, Biohit Oyj, tel. +358 50 383 5948
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com